Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06580782 · ClinicalTrials.gov registry record · Phase 4
Calcium Carbonate to Augment Labor Contractions
A Phase 4 study of Labor Dystocia and Labor Induction, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06580782 is a Phase 4 study of Labor Dystocia and Labor Induction that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 60 participants, below the 213-participant average among 3 other Labor Dystocia trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06580782, a Phase 4 study of Labor Dystocia and Labor Induction, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.
Conditions Studied
Interventions
- DRUG Calcium Carbonate 500 MG
- DRUG Standard Dose Synthetic Pitocin
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-11-18 |
| Est. Completion | 2025-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06580782
The ClinicalTrials.gov registry entry for NCT06580782 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 3 other Labor Dystocia trials with a reported enrollment target (72% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Labor Dystocia appearing as the primary indexed condition, and to 2 interventions - of which Calcium Carbonate 500 MG is the first listed.
NCT06580782 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06580782 about?
NCT06580782 is a clinical study titled "Calcium Carbonate to Augment Labor Contractions". The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.
What is the current status of trial NCT06580782?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2024-11-18. Estimated completion is 2025-12.
What conditions does trial NCT06580782 study?
This clinical trial studies the following conditions: Labor Dystocia, Labor Induction, Labor Augmentation.
What interventions are being tested in trial NCT06580782?
The interventions under investigation include: Calcium Carbonate 500 MG (DRUG), Standard Dose Synthetic Pitocin (DRUG).
Who is sponsoring clinical trial NCT06580782?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06580782 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Labor Dystocia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.